New randomized data from Japan have raised questions regarding the use of prophylactic cranial irradiation for patients with extensive-stage small-cell lung cancer but without detectable brain metastases on magnetic resonance imaging. In the present focused review, we examine the general role of prophylactic cranial irradiation in the management of small-cell lung cancer and present relevant controversies from both sides of the discussion. Future directions for clinical investigation and research are also highlighted. Strategies for neurocognitive protection, including memantine use and hippocampal sparing using modulated radiotherapy techniques, are also presented.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cllc.2018.03.006 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!